Ligand Pharmaceuticals Incorporated Stock Probability of Future Stock Price Finishing Over 120.08
| LGND Stock | USD 120.98 1.05 0.88% |
Ligand |
Ligand Pharmaceuticals Target Price Odds to finish over 120.08
The tendency of Ligand Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 120.08 in 90 days |
| 120.98 | 90 days | 120.08 | about 7.64 |
Based on a normal probability distribution, the odds of Ligand Pharmaceuticals to stay above $ 120.08 in 90 days from now is about 7.64 (This Ligand Pharmaceuticals Incorporated probability density function shows the probability of Ligand Stock to fall within a particular range of prices over 90 days) . Probability of Ligand Pharmaceuticals price to stay between $ 120.08 and its current price of $120.98 at the end of the 90-day period is about 1.5 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.5 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ligand Pharmaceuticals will likely underperform. Additionally Ligand Pharmaceuticals Incorporated has an alpha of 0.0608, implying that it can generate a 0.0608 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ligand Pharmaceuticals Price Density |
| Price |
Predictive Modules for Ligand Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ligand Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ligand Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ligand Pharmaceuticals is not an exception. The market had few large corrections towards the Ligand Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ligand Pharmaceuticals Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ligand Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | 1.50 | |
σ | Overall volatility | 7.96 | |
Ir | Information ratio | 0.04 |
Ligand Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ligand Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ligand Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Ligand Pharmaceuticals director John LaMattina sells 297,501 in stock |
Ligand Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ligand Stock often depends not only on the future outlook of the current and potential Ligand Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ligand Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 17.8 M | |
| Cash And Short Term Investments | 170.3 M |
Ligand Pharmaceuticals Technical Analysis
Ligand Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Ligand Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ligand Pharmaceuticals Incorporated. In general, you should focus on analyzing Ligand Stock price patterns and their correlations with different microeconomic environments and drivers.
Ligand Pharmaceuticals Predictive Forecast Models
Ligand Pharmaceuticals' time-series forecasting models is one of many Ligand Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ligand Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ligand Pharmaceuticals
Checking the ongoing alerts about Ligand Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ligand Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Ligand Pharmaceuticals director John LaMattina sells 297,501 in stock |
Check out Ligand Pharmaceuticals Backtesting, Ligand Pharmaceuticals Valuation, Ligand Pharmaceuticals Correlation, Ligand Pharmaceuticals Hype Analysis, Ligand Pharmaceuticals Volatility, Ligand Pharmaceuticals History as well as Ligand Pharmaceuticals Performance. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.032 | Earnings Share 2.49 | Revenue Per Share 8.509 | Quarterly Revenue Growth 0.576 | Return On Assets 0.013 |
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.